Clinical Trial Update: Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MDMA (Ecstasy) for severe chronic neuropathic pain is currently recruiting at Unity Health Toronto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• MDMA (Ecstasy) (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Unity Health Toronto | Conditions: Chronic Neuropathic Pain | Phase 2 | Status: RECRUITING